Found: 13
Select item for more details and to access through your institution.
Opioid-induced bowel dysfunction: suggestions from a multidisciplinary expert Board.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical–Biological Entity?
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 9, p. 2596, doi. 10.3390/jcm11092596
- By:
- Publication type:
- Article
Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence.
- Published in:
- Cancer Medicine, 2015, v. 4, n. 12, p. 1789, doi. 10.1002/cam4.523
- By:
- Publication type:
- Article
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.
- Published in:
- European Journal of Haematology, 2016, v. 96, n. 4, p. 344, doi. 10.1111/ejh.12595
- By:
- Publication type:
- Article
Combination chemotherapy for acute lymphocytic leukemia in adults: Results of a retrospective study in 82 patients.
- Published in:
- American Journal of Hematology, 1980, v. 8, n. 2, p. 175, doi. 10.1002/ajh.2830080207
- By:
- Publication type:
- Article
Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro.
- Published in:
- European Journal of Neuroscience, 2002, v. 16, n. 4, p. 584, doi. 10.1046/j.1460-9568.2002.02125.x
- By:
- Publication type:
- Article
Pulmonary infections in patients with myelodysplastic syndromes receiving frontline azacytidine treatment.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 5, p. E80, doi. 10.1002/ajh.23966
- By:
- Publication type:
- Article
Real-life experience with azacitidine in myelodysplastic syndromes according to IPSS cytogenetic profile.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 5, p. 565, doi. 10.1002/ajh.23677
- By:
- Publication type:
- Article
Lenalidomide for aggressive B-cell lymphoma involving the central nervous system?
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 11, p. 957, doi. 10.1002/ajh.22148
- By:
- Publication type:
- Article
Specific effects exerted by B-lymphoproliferative diseases on peripheral T-lymphocyte protein expression.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 4, p. 463, doi. 10.1111/j.1365-2141.2010.08285.x
- By:
- Publication type:
- Article
Loss of CDKN1B induces an age‐related clonal hematopoietic disorder via Notch2 activity dysregulation.
- Published in:
- Cancer Communications, 2023, v. 43, n. 7, p. 844, doi. 10.1002/cac2.12444
- By:
- Publication type:
- Article